Combination of enzymes and flow perfusion conditions improves osteogenic differentiation of bone marrow stromal cells cultured upon starch/poly(ε- caprolactone) fiber meshes

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 4, 2010, Pages 1061-1069

  Martins, Ana M ^a,b   Saraf, Anita ^b   Sousa, Rui A ^a   Alves, Catarina M ^a   Mikos, Antonios G ^b   Kasper, F Kurtis ^b   Reis, Rui L ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b Rice University   (United States)

Author keywords

amylase; Flow perfusion bioreactor; Lipase; Osteogenic differentiation; Starch poly( polycaprolactone) fiber meshes

Indexed keywords

BONE MARROW STROMAL CELLS; CALCIUM CONTENT; CAPROLACTONE; DEGRADATION OF FIBERS; DYNAMIC CONDITION; EXTRACELLULAR MATRICES; FIBER MESHES; FLOW CONDITION; FLOW PERFUSION; FLOW PERFUSION BIOREACTOR; HISTOLOGICAL SECTION; MINERAL DEPOSITIONS; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; PRESENCE/ABSENCE; STATIC CULTURE; VON KOSSA STAINING;

BIOCONVERSION; BIOREACTORS; BONE; CALCIUM; CATALYSTS; CELL PROLIFERATION; ENZYMES; FIBERS; FLOWCHARTING; SCAFFOLDS;

CELL CULTURE;

AMYLASE; CALCIUM; POLYCAPROLACTONE; STARCH; TETRACYCLINE; TISSUE SCAFFOLD; TRIACYLGLYCEROL LIPASE;

ANIMAL CELL; ARTICLE; BIOREACTOR; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIUM; DNA CONTENT; EXTRACELLULAR MATRIX; FIBER; FLUORESCENCE; HISTOLOGY; MESH SLING; MINERALIZATION; NONHUMAN; OSTEOBLAST; PERFUSION; RAT; STAINING; STROMA CELL;

ALKALINE PHOSPHATASE; ALPHA-AMYLASES; ANIMALS; BIOLOGICAL ASSAY; BONE MARROW CELLS; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; DNA; ENZYMES; FLUORESCENCE; LIPASE; MALE; MICROSCOPY, ELECTRON, SCANNING; OSTEOGENESIS; PERFUSION; POLYESTERS; RATS; RATS, WISTAR; RHEOLOGY; STAINING AND LABELING; STARCH; STROMAL CELLS; TETRACYCLINE; TISSUE SCAFFOLDS;

EID: 77956493681     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32785     Document Type: Article

References (23)

1. Hutmacher DW, Schantz JT, Lam CXF, Tam KC, Lim TC. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 2007;1:245-260.
2. Gomes ME, Sikavitsas VI, Behravesh E, Reis RL, Mikos AG. Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. J Biomed Mater Res A 2003;67:87-95.
3. Gomes ME, Holtorf HL, Reis RL, Mikos AG. Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. Tissue Eng 2006;12:801-809.
4. Azevedo HS, Gama FM, Reis RL. In vitro assessment of the enzymatic degradation of several starch based biomaterials. Biomacromolecules 2003;4:1703-1712.
5. Balmayor ER, Tuzlakoglu K, Marques AP, Azevedo HS, Reis RL. A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: Combining biodegradable starch-based microparticles and differentiation agents. J Mater Sci Mater Med 2008;19:1617-1623.
6. Gomes ME, Azevedo HS, Moreira AR, Ella V, Kellomaki M, Reis RL. Starch-poly(epsilon-caprolactone) and starch-poly(lactic acid) fibre-mesh scaffolds for bone tissue engineering applications: Structure, mechanical properties and degradation behaviour. J Tissue Eng Regen Med 2008;2:243-252.
7. Martins AM, Santos MI, Azevedo HS, Malafaya PB, Reis RL. Natural origin scaffolds with in situ pore forming capability for bone tissue engineering applications. Acta Biomater 2008;4:1637-1645.
8. Martins AM, Pham QP, Malafaya PB, Sousa RA, Gomes ME, Raphael RM, Kasper FK, Reis RL, Mikos AG. The role of lipase and alpha-amylase in the degradation of starch/poly(epsilon-caprolactone) fiber meshes and the osteogenic differentiation of cultured marrow stromal cells. Tissue Eng Part A 2009;15:295-305.
9. Mochizuki M, Hirano M, Kanmuri Y, Kudo K, Tokiwa Y. Hydrolysis of polycaprolactone fibers by lipase - Effects of draw ratio on enzymatic degradation. J Appl Polym Sci 1995;55:289-296.
10. Zeng J, Chen X, Liang Q, Xu X, Jing X. Enzymatic degradation of poly(L-lactide) and poly(epsilon-caprolactone) electrospun fibers. Macromol Biosci 2004;4:1118-1125.
11. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-430.
12. Beck GR, Zerler B, Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA 2000;97:8352-8357. (Pubitemid 30639676)
13. Bancroft GN, Sikavitsas VI, Van Den Dolder J, Sheffield TL, Ambrose CG, Jansen JA, Mikos AG. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci USA 2002;99:12600-12605.
14. Sikavitsas VI, Bancroft GN, Holtorf HL, Jansen JA, Mikos AG. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci USA 2003;100:14683-14688.
15. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988;254:317-330.
16. Junge W, Troge B, Klein G, Poppe W, Gerber M. Evaluation of a new assay for pancreatic amylase: Performance characteristics and estimation of reference intervals. Clin Biochem 1989;22:109-114.
17. Chawla JS, Amiji MM. Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002;249:127-138.
18. Bancroft GN, Sikavitsas VI, Mikos AG. Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng 2003;9:549-554.
19. Datta N, Holtorf HL, Sikavitsas VI, Jansen JA, Mikos AG. Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation ofmarrow stromal cells. Biomaterials 2005;26:971-977. (Pubitemid 39208984)
20. Sikavitsas VI, Bancroft GN, Lemoine JJ, Liebschner MA, Dauner M, Mikos AG. Flow perfusion enhances the calcified matrix deposition of marrow stromal cells in biodegradable nonwoven fiber mesh scaffolds. Ann Biomed Eng 2005;33:63-70.
21. Pham QP, Sharma U, Mikos AG. Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: Characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules 2006;7:2796-2805.
22. Gomes ME, Bossano CM, Johnston CM, Reis RL, Mikos AG. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng 2006;12:177-188.
23. Frost HM, Vilanueva AR, Jett S, Eyring E. Tetracycline-based analysis of bone remodelling in osteopetrosis. Clin Orthop Relat Res 1969;65:203-217.